Tags

Type your tag names separated by a space and hit enter

[Hereditary nonpolyposis colorectal carcinoma (HNPCC): surgical aspects].
Praxis (Bern 1994). 2001 Mar 22; 90(12):483-9.P

Abstract

1-5% of all patients presenting with colorectal cancer, have an underlying genetic predisposition with an autosomal dominant of pattern of inheritance. Recently the underlying molecular genetic pathway of this syndrome known as HNPCC (hereditary nonpolyposis colorectal cancer) has been characterized: the predisposition is due to a pathogenic mutation in one of the DNA mismatch-repair genes. Colorectal cancers are the leading characterisitic of the syndrom and are frequently encountered at a young age of onset. However, endometrial cancer, stomach cancer, small bowel cancer, urinary tract cancer and skin cancer among others are also inherent to the syndrome. Based on the identification of the underlying molecular genetic pathway, predictive testing has become an option. Once the family-specific underlying pathogenic mutation in one of the DNA mismatch-repair genes has been identified in a proband, at-risk family members may be offered DNA testing with an unequivocal answer to if or if not they have inherited the increased cancer susceptibility. Multiple facets of family DNA testing require a multidisciplinary approach integrating clinicians, geneticists, psychologists, molecular biologist and pathologists. Mutations are identified in a rate of 50-60% of families complying with the Amsterdam criteria for HNPCC. The incidence of recta cancer in HNPCC has as yet not clearly been defined, due to a lack of unequivocal data. In a retrospective analysis (submitted) rectal cancers were encountered in 30% of the HNPCC patients. Half of the patients affected developed metachronous colon cancers. It is essential to address the issue of prophylactic surgery in HNPCC patients presenting with colorectal cancer: Prospective data is required in order to decide which of the options is more beneficial for the HNPCC patient presenting with his first colorectal primary: subtotal colectomy and ileorectal anastomosis versus restorative proctocolectomy. It is evident that apart from the more clinical data quality of life data must be evaluated in this study.

Authors+Show Affiliations

Klinik für Allgemein- und Unfallchirurgie, Heinrich-Heine-Universität Düsseldorf.

Pub Type(s)

English Abstract
Journal Article
Review

Language

ger

PubMed ID

11324307

Citation

Möslein, G. "[Hereditary Nonpolyposis Colorectal Carcinoma (HNPCC): Surgical Aspects]." Praxis, vol. 90, no. 12, 2001, pp. 483-9.
Möslein G. [Hereditary nonpolyposis colorectal carcinoma (HNPCC): surgical aspects]. Praxis (Bern 1994). 2001;90(12):483-9.
Möslein, G. (2001). [Hereditary nonpolyposis colorectal carcinoma (HNPCC): surgical aspects]. Praxis, 90(12), 483-9.
Möslein G. [Hereditary Nonpolyposis Colorectal Carcinoma (HNPCC): Surgical Aspects]. Praxis (Bern 1994). 2001 Mar 22;90(12):483-9. PubMed PMID: 11324307.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Hereditary nonpolyposis colorectal carcinoma (HNPCC): surgical aspects]. A1 - Möslein,G, PY - 2001/4/28/pubmed PY - 2001/7/6/medline PY - 2001/4/28/entrez SP - 483 EP - 9 JF - Praxis JO - Praxis (Bern 1994) VL - 90 IS - 12 N2 - 1-5% of all patients presenting with colorectal cancer, have an underlying genetic predisposition with an autosomal dominant of pattern of inheritance. Recently the underlying molecular genetic pathway of this syndrome known as HNPCC (hereditary nonpolyposis colorectal cancer) has been characterized: the predisposition is due to a pathogenic mutation in one of the DNA mismatch-repair genes. Colorectal cancers are the leading characterisitic of the syndrom and are frequently encountered at a young age of onset. However, endometrial cancer, stomach cancer, small bowel cancer, urinary tract cancer and skin cancer among others are also inherent to the syndrome. Based on the identification of the underlying molecular genetic pathway, predictive testing has become an option. Once the family-specific underlying pathogenic mutation in one of the DNA mismatch-repair genes has been identified in a proband, at-risk family members may be offered DNA testing with an unequivocal answer to if or if not they have inherited the increased cancer susceptibility. Multiple facets of family DNA testing require a multidisciplinary approach integrating clinicians, geneticists, psychologists, molecular biologist and pathologists. Mutations are identified in a rate of 50-60% of families complying with the Amsterdam criteria for HNPCC. The incidence of recta cancer in HNPCC has as yet not clearly been defined, due to a lack of unequivocal data. In a retrospective analysis (submitted) rectal cancers were encountered in 30% of the HNPCC patients. Half of the patients affected developed metachronous colon cancers. It is essential to address the issue of prophylactic surgery in HNPCC patients presenting with colorectal cancer: Prospective data is required in order to decide which of the options is more beneficial for the HNPCC patient presenting with his first colorectal primary: subtotal colectomy and ileorectal anastomosis versus restorative proctocolectomy. It is evident that apart from the more clinical data quality of life data must be evaluated in this study. SN - 1661-8157 UR - https://www.unboundmedicine.com/medline/citation/11324307/[Hereditary_nonpolyposis_colorectal_carcinoma__HNPCC_:_surgical_aspects]_ L2 - https://medlineplus.gov/colorectalcancer.html DB - PRIME DP - Unbound Medicine ER -